1. 2020 online stock market is just difficult and unbelievable, I rather invest my money on crypto

   Reply

2. Useless video from an ignorant youtuber…. Lets be clear and accurate. The stock market is under direct manipulation in every way. It is obvious to all that there is NO FREE MARKET SYSTEM in place with ANY markets. The markets (over decades of effort ) have been converged with the financial banking system as a whole. By way of central bank involvement in the market and countless other means….. the markets are being massively manipulated to the point of being nothing more than a wealth extraction tool for the bankers. Wake up. The public is being played when it comes to their money. We have a global conglomerate enterprise that OWNS AND DIRECTLY CONTROLS all aspects of the United States Dollar and also most 1st and 2nd world currencies on the planet. This entity actually PUT INTO EXISTENCE the Bank of International Settlements and Federal Reserve. The citizens are oblivious for the most part to the astronomical powers this entity has over the globe entire financial system. All videos "gauging" the markets in today's financial situation is completely useless. If the market is up……they want it to be up. If the market is down….. they want it to be down. It is all about global money migration for agenda purposes. The metals markets are exactly the same……TOTAL MANIPULATION. The agenda is sophisticated but usually, it has to do with gross global wealth extraction for their benefit. This video is useless and misdirecting to the truth of what is going on in today's financial world. WAKE THE FUCK UP !!!! RESEARCH. Lets look at todays market…….. ALL TIME MARKET HIGHS ……while the entire financial system is going completely into the toilet with Covid lockdowns. Who in their sound mind would be supporting this market situation. It is BLATANT MANIPULATION.

   Reply

3. You all should consider looking into Agenus (Agen). The company has been around since 1994. They’ve had a rocky road in the past but they now have gotten it together.

   They’re an immuno-therapy company but they also produce cell therapy (INKT’S), through their subsidiary company Agentus and they also produce vaccines.

   They also have the most powerful adjuvant (QS-21) on the market.

   Their main product and near future revenue generators are their PD-1 and CTLA-4 CPMS. Both are currently fast tracked for second line cervical cancer and have currently initiated a rolling BLA submission. The data is compelling and suggests that their PD-1 is as good if not, better than Merck’s Pembro (Keytruda) in CC. And in combination, it’s definitely superior to Keytruda in CC. Projected revenue for the drugs will be around ~165M domestically only. They have also partnered with a chinese pharma company called Betta pharmaceuticals for international rights in greater China. Agenus will be receiving milestone and royalty payments accordingly. Expansion of these two drugs will yield higher revenue. They’re also looking into partnering in Europe. Projected domestic and international revenue could be significantly higher than the ~165m I quoted for domestic sales.

   However, the biggest product they may have could be a potential multi blockbuster which is their next generation CTLA-4 1181. This is what most investors are banking on. They’re already seeing CR’s (complete responses) in Phase 1. It’s showing more than 70 percent clinical benefit (not to be confused with ORR.) It has now entered into phase 2 with label expansion into colorectal cancer.

   Ctla-4 is notorious for being toxic but agenus has manufacturing a very tolerable version that has low toxicity levels. This is huge.

   I believe they have 10 CPMS in the clinic and somewhere around 10 in preclinical. They have partnerships with GILEAD, MERCK, GLAXOSMITHKLINE, INCYTE AND BETTA PHARMACEUTICALS.
   I’ve mentioned most of the pros on the company. The only con is, they need capital to market the product once approved and for label expansion.

   Finally, they also have another drug from their subsidiary company Agentus for the drug AgenT-797 for the treatment of moderate to severe ARDS in COVID-19 patients. The drug is in phase 1 testing. But don’t be fooled; this could be game changer as far as catalysts are concerned.

   GLTAL’S!!

   Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.